Presbyopia

Phentolamine Phase III Data Shows Success in Quickly Reversing Dilation

Roughly half of test subjects—48.9% in one study and 58% in another—saw a return to baseline pupil size within 90 minutes. Hyperemia and discomfort each occurred in about 11% of patients.

09/20/2024

New Daily Multifocal Lens Accommodates More Presbyopes

The “Clariti 1-day Multifocal 3 Add” uses different optical designs for low, medium and high plus powers and offers a wider sphere range than its predecessor.

07/16/2024

Reading Speed, Gaze Behavior Differs Between Types of Presbyopia Correction

Researchers observed variance in head movements between wearers of single-vision contact lenses, multifocal CLs and progressive addition lenses.

04/10/2024

Unhappy Birthday

More trips around the sun means more chances for your patients to develop the dreaded presbyopia.

12/15/2023

Pilocarpine 1.25% Impacts Night Driving

Study shows clinicians should take this into consideration when prescribing the medication to presbyopes.

12/08/2023

FDA Approves Second Presbyopia Drop

A new low-dose pilocarpine agent can be administered up to twice a day for maximum duration of effect. It is hoped to result in fewer adverse effects than Vuity.

10/18/2023

Alcon Adds Multifocal Option to Total30 Line

The company says the new lens is designed to maintain hydration and comfort throughout a month of wear.

10/10/2023

Experts Attempt to Find Consensus on Presbyopic IOL Use

A panel agreed on many aspects of pre-op and intraoperative decision-making. They disagreed, however, when considering issues related to lens selection.

05/31/2023

Vuity Gets Increased Dosing Nod

New, broader latitude for use should overcome some concerns over durability of effect.

03/31/2023

Presbyopia Drugs: A Drop in the Bucket?

With one med available and others coming soon, patients have more options than ever for near vision correction. Do they offer enough to make a difference in a well-established market?

03/15/2023